Statistics of hematologic malignancies in korea: Incidence, prevalence and survival rates from 1999 to 2008

Korean Journal of Hematology

Volumn 47, Issue 1, 2012, Pages 28-38

  Park, Hyeon Jin ^a   Park, Eun Hye ^a   Jung, Kyu Won ^a   Kong, Hyun Joo ^a   Won, Young Joo ^a   Lee, Joo Young ^a   Yoon, Jong Hyung ^a   Park, Byung Kiu ^a   Lee, Hyewon ^a   Eom, Hyeon Seok ^a   Park, Sohee ^a  

^a National Cancer Center   (South Korea)

Author keywords

Hematologic malignancy; Incidence; Korea; Prevalence; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER STATISTICS; CANCER SURVIVAL; FEMALE; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; KOREA; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; MYELOPROLIFERATIVE DISORDER; NONHODGKIN LYMPHOMA; PREVALENCE; SURVIVAL RATE;

EID: 84866894342     PISSN: 17387949     EISSN: 20929129     Source Type: Journal    
DOI: 10.5045/kjh.2012.47.1.28     Document Type: Article

References (24)

1. Storm HH, Klint A, Tryggvadóttir L, et al. Trends in the survival of patients diagnosed with malignant neoplasms of lymphoid, haematopoietic, and related tissue in the Nordic countries 1964-2003 followed up to the end of 2006. Acta Oncol 2010;49: 694-712.
2. Pulte D, Gondos A, Brenner H. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005. Cancer 2009;115:4973-9.
3. Sant M, Allemani C, Tereanu C, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010;116:3724-34.
4. Marcos-Gragera R, Allemani C, Tereanu C, et al. Survival of European patients diagnosed with lymphoid neoplasms in 2000-2002: results of the HAEMACARE project. Haematologica 2011;96:720-8.
5. Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007;110:695-708.
6. Ministry of Health and Welfare. The Korea central cancer registry. Annual report of cancer statistics in Korea in 2008. Seoul,Korea: Ministry of Health and Welfare, 2010.
7. Fritz A, Percy C, Jack A, et al, eds. International classification of diseases for oncology. 3rd ed. Geneva, Switzerland: World Health Organization, 2000.
8. World Health Organization. International statistical classification of diseases and related health problems (ICD-10) in occupational health. Geneva, Switzerland: World Health Organization, 1999.
9. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-51.
10. Lee ET, Wang JW, eds. Statistical methods for survival data analysis. 3rd ed. Hoboken, NJ: John Wiley & Sons Inc, 2003.
11. National Cancer Institute. SEER*Stat software program, version 7.0.5. Bethsda, MD: National Cancer Institute, 2011. (Accessed February 7, 2012, at http://seer.cancer.gov/seerstat/).
12. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v1.2. Cancer incidence, mortality and prevalence worldwide in 2008. IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer, 2010. (Accessed December 1, 2011, at http://globocan.iarc.fr/).
13. Rollison DE, Howlader N, Smith MT, et al. Epidemiology of myelodysplastic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 2008;112:45-52.
14. Mester B, Nieters A, Deeg E, Elsner G, Becker N, Seidler A. Occupation and malignant lymphoma: a population based case control study in Germany. Occup Environ Med 2006;63:17-26.
15. Eden T. Aetiology of childhood leukaemia. Cancer Treat Rev 2010;36:286-97.
16. Alexander FE. The search for causes of the leukaemias. Eur J Cancer 1995;31:863-7.
17. Bezabeh S, Engel A, Morris CB, Lamm SH. Does benzene cause multiple myeloma? An analysis of the published case-control literature. Environ Health Perspect 1996;104(Suppl 6):1393-8.
18. Alexander DD, Mink PJ, Adami HO, et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 2007;120(Suppl 12):1-39.
19. Gorini G, Stagnaro E, Fontana V, et al. Alcohol consumption and risk of leukemia: a multicenter case-control study. Leuk Res 2007;31:379-86.
20. Cook MB, Dawsey SM, Freedman ND, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev 2009;18:1174-82.
21. Sankaranarayanan R, Swaminathan R, Jayant K, Brenner H. An overview of cancer survival in Africa, Asia, the Caribbean and Central America: the case for investment in cancer health services. IARC Sci Publ 2011;162:257-91.
22. Howlader N, Noone AM, Krapcho M, et al. SEER cancer statistics review, 1975-2008. Bethesda, MD: National Cancer Institute, 2011. (Accessed December 1, 2011, at http://seer.cancer.gov/ statfacts/html/all.html).
23. Jung KW, Park S, Kong HJ, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2008. Cancer Res Treat 2011;43:1-11.
24. Howell D, Hack TF, Oliver TK, et al. Survivorship services for adult cancer populations: a pan-Canadian guideline. Curr Oncol 2011;18:e265-81.